» Articles » PMID: 28545588

Patterns of Local-regional Recurrence After Conformal and Intensity-modulated Radiotherapy for Head and Neck Cancer

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2017 May 27
PMID 28545588
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate the patterns of loco-regional recurrences in head and neck cancer patients METHODS: Twenty-six out of 112 patients treated with primary or postoperative 3D CRT or IMRT for their primary and recurrent disease between 2007 and 2013 were included. The CT images of recurrent disease were rigidly registered with the primary CT images for each patient. To assess overlaps and overlap localization, the recurrence volume overlapping with the primary target volume was identified. For relapses occurring in the regional lymph nodes, the epicenter distance in recurrences and primary volumes and dose in recurrences were also identified. The recurrences were defined as in-field, marginal or out-of-field.

Results: The majority of the failures occurred within 1 year after completed primary treatment. The dose differences in recurrence volume were not statistically significant when patients were treated with IMRT or 3D CRT. Recurrence in 15/26 of the included patients occurred in the regional lymph nodes located fully or partly inside the primary target volume or the elective lymph node region. The majority of recurrences were recognized as in-field, independent of the primary treatment.

Conclusion: Recurrence in the majority of the patients occurred in the regional lymph nodes located in high dose area. The cause of recurrence may be due to inadequate total dose in the primary treatment and/or lack of optimal primary diagnosis leading to inadequate primary target delineation.

Citing Articles

Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy.

Belfiore M, Nardone V, DOnofrio I, Pirozzi M, Sandomenico F, Farese S Biomedicines. 2024; 12(9).

PMID: 39335592 PMC: 11428618. DOI: 10.3390/biomedicines12092080.


Correlation Between Dosimetric Parameters and Local Control in Definitive Radiotherapy for Head and Neck Cancers.

Yamashita M, Ohira S, Tanabe H, Kokubo M, Koizumi M In Vivo. 2024; 38(2):819-825.

PMID: 38418123 PMC: 10905467. DOI: 10.21873/invivo.13506.


MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.

You G, Cheng A, Shen E, Fan K, Huang Y, Huang Y Cells. 2023; 12(24).

PMID: 38132173 PMC: 10741482. DOI: 10.3390/cells12242853.


6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma.

Hsu C, Su H, Yang M, Tsai Y, Tsai M, Yang Y Int J Med Sci. 2023; 20(2):238-246.

PMID: 36794162 PMC: 9925991. DOI: 10.7150/ijms.80542.


Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring Approach.

Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M J Clin Med. 2021; 10(20).

PMID: 34682782 PMC: 8537676. DOI: 10.3390/jcm10204653.


References
1.
Ng W, Lee M, Hung W, Choi C, Lee K, Chan O . Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2010; 79(2):420-8. DOI: 10.1016/j.ijrobp.2009.11.024. View

2.
Soto D, Kessler M, Piert M, Eisbruch A . Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol. 2008; 89(1):13-8. PMC: 2684445. DOI: 10.1016/j.radonc.2008.05.021. View

3.
Mendenhall W, Amdur R, Palta J . Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006; 24(17):2618-23. DOI: 10.1200/JCO.2005.04.7225. View

4.
Eisbruch A, Marsh L, Martel M, Ship J, Haken R, Pu A . Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys. 1998; 41(3):559-68. DOI: 10.1016/s0360-3016(98)00082-0. View

5.
Dawson L, Anzai Y, Marsh L, Martel M, Paulino A, Ship J . Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000; 46(5):1117-26. DOI: 10.1016/s0360-3016(99)00550-7. View